|Articles|June 16, 2022
Yseop’s AI Natural Language Platform Scaled by Sanofi to Accelerate Medical Writing and Reporting Processes
After four successful years of collaborating, Sanofi plans to expand Yseop’s platform for pharma and vaccine use cases.
Advertisement
Yseop announced that Sanofi has chosen to scale its natural language generation (NLG) capabilities with Yseop. Sanofi will use the platform to accelerate its clinical study submission processes and bring new treatments to patients faster.
Read more about platform
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
